Acquisition Momentum Solvias USA, LLC is the result of Solvias Group acquiring Chemiclabs, signaling a growth strategy and potential integration opportunities for cross-selling CRO and manufacturing services to a broader client base.

Regulatory Expertise With FDA registration, DEA licensing, and capabilities in regulated QC monograph testing, CMC data production, and bio-analytical analysis, there are ample upsell opportunities to current pharma, biotech, and medical device clients seeking compliant external testing and development support.

Diverse Clientele Serving Fortune 100 to virtual companies across pharmaceuticals, biotech, veterinary medicine, medical devices, and specialty chemicals suggests a broad footprint and potential for tailored service packages that address varied regulatory and quality requirements.

Mid Market Growth Revenue in the small-to-mid market range coupled with a mid-sized employee base indicates agility for rapid quote-to-delivery cycles and scalable projects, ideal for expanding consulting, analytics, and small-scale manufacturing engagements.

Tech Stack Advantage Adoption of widely-used tools and platforms (Microsoft 365, Google Cloud, React, and Bootstrap) facilitates efficient collaboration and modern data workflows, enabling you to pitch enhanced digital data management, cloud-based reporting, and accelerated project onboarding to prospective clients.